Datlowe

Datlowe develops AI applications that analyse hospital data to detect clinical risks early. Its products are HAIDI, for real-time hospital infection monitoring, and MERIE, for real-time pharmacotherapy monitoring. The website states that the applications are deployed on-premise and aligned with SNOMED CT and FHIR standards.

The customers are hospitals and their clinical teams, such as infection control, hygiene and epidemiology, and clinical pharmacy departments. Testimonials on the website come from hospitals in the Czech Republic, Slovakia and Austria. The website does not describe the pricing or revenue model.

The company is registered in Prague, Czechia, and the registry gives 2014 as its founding year, while the website says it has been transforming hospital data since 2017. The website states that its applications are used in more than 55 hospitals across Europe, and also cites 45 hospitals across Central and Eastern Europe. Recent public activity listed on the site includes conference presentations and webinars in 2026.

Product: HAIDI, an AI tool for real-time hospital infection monitoring, and MERIE, an AI tool for real-time pharmacotherapy risk monitoring, both deployed on-premise.